Delivery Order SPE2DB20D3103-SPE2DB22FM1T8

Award Date 1/4/22
Potential Completion Date 1/5/22
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ezetimibe 10 mg tablets. The $2,981.16 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 30, 2025. The contract is a delivery order and does not appear to have any set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP39H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.86 Firm Fixed Price delivery order is for the provision of 4564996823 - EZETIMIBE 10 MG TABLET 500S. The contract has an ultimate completion date of June 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, with the ID SPE2DB20D3505|SPE2DB24FU2J5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order, has a Firm Fixed Price pricing type and a ceiling value of $2,598.26. It is for the supply of EZETIMIBE-SIMVASTATIN 10-20 MG 30S, a pharmaceutical product, with a performance location in Conshohocken, Pennsylvania. The contract has an ultimate completion date of May 8, 2024....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the delivery of Ezetimibe 10 mg tablets, a prescription medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award has a ceiling value of $1,383.02 and a...
This contract award, SPE2DB22D3004|SPE2DB24FPH74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,040.44 firm fixed-price delivery order is for the supply of 4563666654 EZETIMIBE 10 MG TABLET 500S, a pharmaceutical product. The contract has a period of performance through February 15, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of ezetimibe 10 mg tablets. The $5,195.71 firm fixed-price contract has a completion date of February 8, 2023. Amerisourcebergen has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order is for the pharmaceutical product Ezetimibe 10 mg Tablet, 500 units, with a ceiling value of $5,335.10. The contract is a Firm Fixed Price type, with a performance period ending on August 10, 2021. This contract is not designated with a set-aside. Cencora, Inc. holds a larger IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Simvastatin 40 mg tablets in quantities of 1,000 tablets. The contract is a firm-fixed-price, delivery order contract with a ceiling value of $3,332.84 and a performance period through August 8, 2023. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,131.53 for the supply of 4,562,967,762 units of Simvastatin 20 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of December 4, 2023. This award is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for $2,698.87 and was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for ezetimibe 10 mg tablets, a cardiovascular medication, with a completion date of July 2, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM1T8
    Delivery Order

This federal contract award is for the delivery of 4555835777 EZETIMIBE-SIMVASTATIN 10-40 MG 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,959.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 4, 2022 with a completion date of January 5, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables Cencora, Inc. to efficiently provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order was not designated with a set-aside.

Generated 2/27/25, 11:33 AM